PAR 0.00% 21.0¢ paradigm biopharmaceuticals limited..

Where we at?, page-395

  1. 740 Posts.
    lightbulb Created with Sketch. 168
    spend will be $14-$15m but after $7.36m R7D rebate will see outflows of $7-$8m leaving circa $25m with current quarter cash burn expected to be $6-8m so enough runway to see through for a bit yet I believe.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.